StonvexLoading…
StonvexStonvexStonvexCore line items from ATHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $674.85K | $338.80K | $1.38M | $1.04M |
Operating Income | $-2.33M | $-1.30M | $-3.14M | $-1.71M |
Net Income | $-2.33M | $-1.30M | $-3.14M | $-1.72M |
EPS (Diluted) | $-0.19 | $-0.11 | $-0.29 | $-0.16 |
Total Assets | $2.98M | $4.01M | $5.04M | $6.52M |
Total Liabilities | $640.76K | $637.09K | $519.08K | $582.69K |
Cash & Equivalents | $215.88K | $263.32K | $159.56K | $187.42K |
Free Cash Flow OCF − CapEx | $-3.10M | $-2.18M | $-3.57M | $-2.00M |
Shares Outstanding | 12.14M | 12.14M | 12.10M | 12.10M |